Prospective Evaluation Of Abl Kinase Domain Mutational Analysis By Next-Generation-Sequencing In Newly Diagnosed Cp Cml Patients Undergoing First-Line Treatment With Nilotinib Alone Or Nilotinib Plus Pegylated Interferon-Alpha 2a In A Prospective Phase Iii Trial

Hugues De Lavallade,Sophie Jackson,Aytug Kizilors,Gabriel Etienne,Francoise Huguet,Agnes Guerci-Bresler,Delphine Rea,Claudine Chollet,Stephane Morisset,Fanny Robbesyn,Francois-Xavier Mahon,Stephanie Dulucq,Franck E. Nicolini

BLOOD（2019）

引用 4|浏览19

暂无评分

关键词

cp cml patients,kinase,nilotinib,next-generation-sequencing,first-line

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要